| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Future Medicinal Chemistry (Q3) | ||
| Dergi ISSN | 1756-8919 Dergi Bilgileri (2026) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 06-2026 |
| Cilt / Sayı / Sayfa | 18 / 12 / 1481–1494 | DOI | 10.1080/17568919.2026.2675874 |
| Makale Linki | https://doi.org/10.1080/17568919.2026.2675874 | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| AimThis study aimed to synthesize a new series of thiosemicarbazone derivatives (4a-r) as multifunctional antidiabetic candidates with dual α-glucosidase (α-Glu) inhibitory and antioxidant activities to address both hyperglycemia and oxidative stress in diabetes management.Materials and methodsCompounds were synthesized and characterized spectroscopically. The in vitro studies were done on compounds for α-Glu inhibitory and metal-chelating properties. The docking studies and MM-GBSA experimental analyses were implemented for the evaluation of binding strength, coupled with 500 ns molecular dynamics in order to validate the stability of the enzyme-ligand complex. ADME prediction tools were employed to evaluate pharmacokinetic suitability.ResultsCompound 4d (p-methylbenzyl) showing the strongest α-Glu inhibition (IC50 = 206.91 nM, Ki = 235.86 nM), significantly surpassing acarbose … |
| Anahtar Kelimeler |
| antioxidant | Aryl sulfonate | diabetes mellitus | molecular dynamics | thiosemicarbazone |
| Atıf Sayıları | |
| Google Scholar | 1 |
| Dergi Adı | Future Medicinal Chemistry |
| Kısa Adı | FUTURE MED CHEM |
| Yayıncı | TAYLOR & FRANCIS LTD |
| Açık Erişim | Hayır |
| ISSN | 1756-8919 |
| E-ISSN | 1756-8927 |
| Wos Quartile | Q3 |
| Scopus Quartile | Q3 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | CHEMISTRY, MEDICINAL |
| Scopus Kategoriler | DRUG DISCOVERY | PHARMACOLOGY | MOLECULAR MEDICINE |